June 12, 2021 | News
BIRMINGHAM, UK: To fill a research gap, researchers have recently examined whether dental professionals are, in fact, at an increased risk of becoming infected with SARS-CoV-2 in the workplace, as has often been hypothesised. They found that close contact with patients put dental professionals at a higher risk of developing COVID-19 during the first wave of the pandemic and that a large number of dental professionals had SARS-CoV-2 antibodies in their blood.
May 29, 2021 | News
Information on the transmission of the SARS-CoV-2 virus has constantly been evolving right from droplet spread to the virus being declared airborne. The acknowledgment of airborne transmission prioritizes ventilation along with masks, hand hygiene, and social distancing. This article focuses on ventilation, the most critical measure to curb the spread by intentionally introducing outdoor air into closed spaces.
May 28, 2021 | News
The 74th World Health Assembly (WHA74) has approved the landmark resolution on putting oral health back on the global agenda.
May 25, 2021 | News
The Covid-19 pandemic has unleashed a flood of Mucormycosis cases in India. All specialists - the ENT/ ophthalmic/ maxillofacial surgeons, physicians, and radiologists are working on its early diagnosis, early radical surgical debridement, and medical management with Liposomal Amphotericin B. However, it is equally critical to explore the other end of the spectrum, i.e., the site of initial fungal spore invasion-the nostrils. Dr. Puneet Wadhwani (OMFS) suggests the use of acetic acid as a simple, readily available, and inexpensive measure - worth exploring further for the prevention of mucormycosis.
May 21, 2021 | News
This is a series of updates by Dr. Rohan Bandi (MDS) Prosthodontist, Mumbai on the emerging lines of evidence on B.1.617.2, the Indian variant of SARS-CoV-2. Part 3 of the series describes the current status of B.1.617 and the impact of its mutations on the vaccines .
May 18, 2021 | News
Our interest in the significance of T-cell immunity in fighting SARS-CoV-2 infection and in providing resistance to re-infection is only growing more. Now, we have the first clinical T-cell-based test for patients to confirm recent or prior COVID-19 infection.
May 15, 2021 | News
This is a series of updates by Dr. Rohan Bandi (MDS) Prosthodontist, Mumbai on the emerging lines of evidence on B.1.617.2, the Indian variant of SARS-CoV-2. Part 2 of the series describes the basics of B.1.617 and clarifies the different terms used in the description of variants, especially the Indian variants.
May 12, 2021 | News
Sumita Mitra, an Indian-American chemist, has been nominated as a finalist for the European Inventor Award 2021 for applying nanotechnology to produce a new composite restorative material, which has many advantages over conventional materials.
May 10, 2021 | News
As the COVID-19 vaccination drive continues to expand throughout the world, SARS-CoV-2 variant mutations and breakthrough infections have posed a new public health concern.
May 9, 2021 | News
Several media reports have come up with scary headlines that the new SARS-CoV-2 variants are fooling the RT-PCR test, which is considered the gold standard test for detecting the SARS-CoV-2 infection. Anecdotal reports say PCR tests are not able to detect the virus due to the new mutations. Is it true? Let us explore science and find out the truth.
May 4, 2021 | News
The World Health Organization (WHO) updated its communication on the airborne transmission of SARS-CoV-2 on 30 April 2021. This article summarizes their current opinion.
April 29, 2021 | News
The use of saliva has multiple advantages over nasopharyngeal swabs in terms of being non-invasive, its ease of collection without professional help, and without the need for transport media. The growing evidence on saliva being as accurate as nasopharyngeal swab test makes it a potential alternative diagnostic test especially in times like these when testing demands have surged.
April 26, 2021 | News
The measured efficacy/ effectiveness of the vaccine is only a guide for approval and not a benchmark for claiming superiority of one vaccine over another.